Company profile: Sedana Medical
1.1 - Company Overview
Company description
- Provider of anaesthetic delivery systems and agents, including the AnaConDa (Anaesthetic Conserving Device) for delivering anaesthetic agents during medical procedures; Sedaconda (isoflurane) for sedation with AnaConDa; Sedasource for continuous anaesthetic agent supply; and FlurAbsorb to absorb and manage anaesthetic gases in medical settings.
Products and services
- Sedaconda (isoflurane): Pharma-grade isoflurane anaesthetic agent used with AnaConDa for patient sedation during procedures, engineered to work in conjunction with device-based delivery of anaesthetic agents
- AnaConDa (Anaesthetic Conserving Device): Clinical-grade anaesthetic delivery device that conserves and delivers anaesthetic agents during medical procedures, with over 300,000 units used worldwide and advantages evidenced by more than 70 publications
- Sedasource: Modular anaesthetic supply system engineered to deliver a continuous supply of anaesthetic agents in medical settings, ensuring uninterrupted availability of agents for sedation procedures
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Sedana Medical
Lexaria Bioscience
HQ: Canada
Website
- Description: Provider of patented DehydraTECH technology that improves bio-absorption, reduces onset time, and enhances delivery of lipophilic drugs across the blood-brain barrier; out-licenses this platform and operates units focused on pharmaceuticals (hypertension, antiviral, epilepsy), oral non-combusted nicotine, hemp-derived ingredients, a Health Canada licensed lab for cannabinoid and other formulations, and nutraceutical CPG applications.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lexaria Bioscience company profile →
Cure Pharmaceutical
HQ: United States
Website
- Description: Provider of specialty pharmaceutical and bioscience drug formulation and delivery technologies, featuring the CUREfilm thin-film platform for sublingual and buccal delivery. Offerings include CUREfilm Blue (sildenafil for ED), oral thin-film insulin, CU-2025g for weight management, an oral Hepatitis B vaccine, and CUREfilm-based nutraceuticals.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cure Pharmaceutical company profile →
Virpax Pharmaceuticals
HQ: United States
Website
- Description: Provider of intranasal and topical therapeutics for pain, epilepsy, and viral inhibition, including: Probudur, a single-injection liposomal bupivacaine for extended post-operative pain; Envelta, intranasal enkephalin for acute/chronic and cancer pain; NobrXiol, intranasal CBD for rare pediatric epilepsy; AnQlar, intranasal spray to inhibit influenza/SARS-CoV-2; and Epoladerm, topical diclofenac spray film for osteoarthritis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Virpax Pharmaceuticals company profile →
Elektrofi
HQ: United States
Website
- Description: Provider of a microparticle platform (Hypercon) enabling low-volume, stable, hyper-concentrated biologic formulations for subcutaneous delivery, alongside formulation development services—covering process development, formulation, analytics, and innovation—and partnership programs with pharmaceutical companies to develop and commercialize subcutaneous biologic therapies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Elektrofi company profile →
Alliqua
HQ: United States
Website
- Description: Provider of biomedical products and therapies, including custom electron-beam cross-linked hydrogels for medical and cosmetic applications and the UltraMIST ultrasound wound-healing therapy; develops, manufactures, and markets proprietary products leveraging a technology portfolio.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Alliqua company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Sedana Medical
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Sedana Medical
2.2 - Growth funds investing in similar companies to Sedana Medical
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Sedana Medical
4.2 - Public trading comparable groups for Sedana Medical
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →